What did @dr.pedronunes actually say?
Honestly? It's hard to tell. The transcript for this 53.5K-view TikTok is a garbled, incoherent string of sentences about New Zealand, Korea, and someone being a "very powerful CEO." It bears no readable relationship to the caption, which calls an unnamed peptide "extremamente promissor" (extremely promising). There is no decipherable scientific claim in the transcript as provided.
This matters because the video is categorized under peptide therapy and tagged with a caption making a strong efficacy claim. Viewers are presumably watching to learn something about a peptide. If the audio was auto-transcribed from Portuguese and mangled beyond recognition, that is a data quality failure, not a minor footnote. We cannot responsibly attribute specific claims to this creator based on what amounts to nonsense text.
Does the science back this up?
Since the caption references an unnamed "extremely promising" peptide in the therapy category, the most charitable reading is that this video discusses something like BPC-157, TB-500, or a similar research peptide. On that basis alone, here is what the evidence actually shows.
BPC-157 has demonstrated anti-inflammatory and tissue-repair effects in rodent models. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated tendon and ligament healing in rats. TB-500 (Thymosin Beta-4) shows similar preclinical promise for cardiac and musculoskeletal repair. GHK-Cu has shown collagen synthesis activity in cell cultures (Pickart et al., 2015, Journal of Aging Research).
The critical gap: virtually none of these have completed Phase III human clinical trials. "Extremely promising" in rodents has burned researchers before. The history of peptide research is full of compounds that looked transformative in animal models and stalled or failed in humans.
What did they get wrong (or right)?
We cannot fairly say the creator got specific facts wrong, because the transcript is unreadable. What we can flag is the framing problem. The caption uses "extremamente promissor" as a standalone claim with no named peptide, no mechanism, no study citation, and no caveat. That is a pattern worth calling out regardless of what was said in the video itself.
Peptide content on TikTok routinely collapses the distance between "shows activity in a cell culture" and "will work in your body." That gap is not a technicality. It is the entire question. A creator with medical credentials (the "dr." prefix) carries a higher responsibility to contextualize preclinical enthusiasm with honest discussion of where human evidence is thin or absent. The caption alone does not meet that bar.
- No peptide named in caption or readable transcript.
- No mechanism or study referenced.
- No regulatory or safety context provided.
What should you actually know?
If you found this video while researching peptide therapy, here is what the actual evidence supports and where it stops.
BPC-157 remains unapproved by the FDA and most global regulators. The FDA has specifically restricted its use in compounded preparations. Sikiric's rodent data is genuinely interesting, but animal-to-human translation for peptides is notoriously unreliable due to differences in bioavailability, receptor distribution, and metabolism. TB-500 is similarly unapproved for human use outside clinical trials. MK-677, sometimes grouped with peptides, is an oral ghrelin mimetic with some human data on GH secretion (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism), but long-term safety data in healthy adults is limited.
Semax and Selank have more human trial data, largely from Russian research institutions, but that literature has reproducibility and methodology concerns that Western regulatory bodies have not resolved. None of these compounds should be treated as equivalent to approved pharmaceuticals. Anyone offering them via telehealth should be operating under a formal informed-consent framework with documented clinical rationale.